Search

Issue
Title
Authors
Vol 21, No 4 (2025)
From clinical trials to routine practice: 7-year results of the monarchE randomized clinical trial and experience with the use of abemaciclib in hormone-dependent, HER2-negative, high-risk, early breast cancer
Kolyadina I.V., Khokhlova S.V., Bikeev Y.V., Zaytsev N.A., Poddubnaya I.V.
PDF
(Rus)
Vol 19, No 3 (2023)
Modern possibilities for the correction of menopausal symptoms in patients with breast cancer, depending on the molecular biological characteristics of the tumor (literature review)
Vysotskaya I.V., Kim E.A., Geletko M.V., Misrikhanova F.E., Kirsanov V.Y.
PDF
(Rus)
Vol 15, No 4 (2019)
Prevention of vaginal atrophy after treatment for tumors of the female reproductive system
Kedrova A.G.
PDF
(Rus)
Vol 21, No 3 (2025)
Clinical and demographic characteristics of patients with hormone-sensitive HER2-negative advanced breast cancer receiving ribociclib in combination with endocrine therapy or combination chemotherapy in routine clinical practice in the Russian Federation: interim results of the ValerEE study
Zhukova L.G., Artamonova E.V., Vladimirova L.Y., Vinogradova T.V., Voronkova L.M., Zhikhorev R.S., Leushina N.V., Mironov O.V., Reznikov V.А., Semenov E.V.
PDF
(Rus)
Vol 17, No 2 (2021)
Ribociclib in the treatment of HR+ HER2-negative metastatic breast cancer: updated results from the randomized clinical trials and their role in the clinical practice
Kolyadina I.V.
PDF
(Rus)
Vol 14, No 1 (2018)
MODERN VIEWS ON THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER: SABCS-2017 NEWS
Bozhok A.A.
PDF
(Rus)
Vol 21, No 2 (2025)
The role of ribociclib in the treatment of early hormone receptor-positive HER2-negative breast cancer: 4-year results of the randomized controlled phase 3 trial NATALEE and their reconsideration for clinical practice
Kolyadina I.V.
PDF
(Rus)
Vol 12, No 2 (2016)
Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations
Imyanitov E.N.
PDF
(Rus)
No 1 (2011)
Current feasibility of endocrine therapy for breast cancer
Vysotskaya I.V.
PDF
(Rus)
Vol 20, No 1 (2024)
Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why?
Kolyadina I.V.
PDF
(Rus)
1 - 10 of 10 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"